Skip to content

Clinical trials

Phase 3 Macular Degeneration trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20082
20131
20141
20153
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Ophthotech Corporation2
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery2
Allergan1
Astellas Pharma Global Development, Inc.1
Bioeq GmbH1
IVERIC bio, Inc.1
Medical University of Vienna1
NeoVista1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration15
Choroidal Neovascularization4
Geographic Atrophy4
Eye Diseases3
Retinal Diseases3
Retinal Degeneration2
Vision Disorders2
Wet Macular Degeneration2
Blindness1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.